Mode of cytotoxic action of T cell-engaging BiTE antibody MT110-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110

Published:2009-06 Issue:6 Volume:214 Page:441-453
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Haas Cornelia,Krinner Eva,Brischwein Klaus,Hoffmann Patrick,Lutterbüse Ralf,Schlereth Bernd,Kufer Peter,Baeuerle Patrick A.

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference35 articles.

1. BiTE: a new class of antibodies that recruit T-cells;Baeuerle;Drugs Future,2008

2. Tumor regression in cancer patients by very low doses of a T cell-engaging antibody;Bargou;Science,2008

3. MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors;Brischwein;Mol. Immunol.,2006

4. Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE class;Brischwein;J. Immunother.,2007

5. Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM×anti-CD3 antibody: a phase I/II study;Burges;Clin. Cancer Res.,2007

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy;Trends in Molecular Medicine;2024-08

2. IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer;International Immunopharmacology;2024-08

3. Camelid‐derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents;European Journal of Immunology;2024-05-28

4. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion;Molecular Biology Reports;2024-04-25

5. Targeting Prostate Cancer Using Bispecific T-Cell Engagers against Prostate-Specific Membrane Antigen;ACS Pharmacology & Translational Science;2023-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3